Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo
Covington
Colorcon
Teva
Cerilliant
UBS

Generated: December 11, 2017

DrugPatentWatch Database Preview

Procainamide hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for procainamide hydrochloride and what is the scope of procainamide hydrochloride freedom to operate?

Procainamide hydrochloride
is the generic ingredient in seven branded drugs marketed by Ascot, Idt Australia Ltd, Ivax Sub Teva Pharms, Lannett, Lederle, Roxane, Vangard, Watson Labs, Parke Davis, Panray, Apothecon, Abraxis Pharm, Hospira, Intl Medication, Nexus Pharms, Pharmafair, Smith And Nephew, Solopak, Warner Chilcott, West-ward Pharms Int, Ani Pharms Inc, Inwood Labs, Sandoz, Parkedale, and King Pharms, and is included in seventy NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for procainamide hydrochloride. Five suppliers are listed for this compound.

Pharmacology for procainamide hydrochloride

Drug ClassAntiarrhythmic

Medical Subject Heading (MeSH) Categories for procainamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Watson LabsPROCAINAMIDE HYDROCHLORIDEprocainamide hydrochlorideCAPSULE;ORAL083795-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Abraxis PharmPROCAINAMIDE HYDROCHLORIDEprocainamide hydrochlorideINJECTABLE;INJECTION089416-001Nov 17, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsPROCAINAMIDE HYDROCHLORIDEprocainamide hydrochlorideTABLET, EXTENDED RELEASE;ORAL088534-001Dec 3, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
PanrayPROCAPANprocainamide hydrochlorideCAPSULE;ORAL083553-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ApotheconPRONESTYLprocainamide hydrochlorideTABLET;ORAL017371-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Warner ChilcottPROCAINAMIDE HYDROCHLORIDEprocainamide hydrochlorideINJECTABLE;INJECTION089529-001May 3, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
ParkedalePROCAN SRprocainamide hydrochlorideTABLET, EXTENDED RELEASE;ORAL088489-001Jan 16, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
VangardPROCAINAMIDE HYDROCHLORIDEprocainamide hydrochlorideCAPSULE;ORAL087643-001Jun 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
King PharmsPROCANBIDprocainamide hydrochlorideTABLET, EXTENDED RELEASE;ORAL020545-001Jan 31, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsPROCAINAMIDE HYDROCHLORIDEprocainamide hydrochlorideCAPSULE;ORAL087021-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: procainamide hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
King PharmsPROCANBIDprocainamide hydrochlorideTABLET, EXTENDED RELEASE;ORAL020545-002Jan 31, 1996► Subscribe► Subscribe
King PharmsPROCANBIDprocainamide hydrochlorideTABLET, EXTENDED RELEASE;ORAL020545-001Jan 31, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Healthtrust
US Army
Daiichi Sankyo
Covington
Chubb
Accenture
McKesson
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot